Michael Roimi1, Ami Neuberger2, Anat Shrot3, Mical Paul4, Yuval Geffen5, Yaron Bar-Lavie6. 1. Intensive Care Unit, Rambam Health Care Campus, HaAliya HaShniya St 8, 31096, Haifa, Israel. m_roimi@rambam.health.gov.il. 2. Infectious Disease Division, Rambam Health Care Campus, Haifa, Israel. 3. , Haifa, Israel. 4. Head of Infectious Disease Division, Rambam Health Care Campus, Haifa, Israel. 5. Head of the Microbiologic Laboratory, Rambam Health Care Campus, Haifa, Israel. 6. Head of Intensive Care Division, Rambam Health Care Campus, Chairman of the Israeli Society of Intensive Care Medicine, Haifa, Israel.
Abstract
PURPOSE: We aimed to develop a machine-learning (ML) algorithm that can predict intensive care unit (ICU)-acquired bloodstream infections (BSI) among patients suspected of infection in the ICU. METHODS: The study was based on patients' electronic health records at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, USA, and at Rambam Health Care Campus (RHCC), Haifa, Israel. We included adults from whom blood cultures were collected for suspected BSI at least 48 h after admission. Clinical data, including time-series variables and their interactions, were analyzed by an ML algorithm at each site. Prediction ability for ICU-acquired BSI was assessed by the area under the receiver operating characteristics (AUROC) of ten-fold cross-validation and validation sets with 95% confidence intervals. RESULTS: The datasets comprised 2351 patients from BIDMC (151 with BSI) and 1021 from RHCC (162 with BSI). The median (inter-quartile range) age was 62 (51-75) and 56 (38-69) years, respectively; the median Acute Physiology and Chronic Health Evaluation II scores were 26 (21-32) and 24 (20-29), respectively. The means of the cross-validation AUROCs were 0.87 ± 0.02 for BIDMC and 0.93 ± 0.03 for RHCC. AUROCs of 0.89 ± 0.01 and 0.92 ± 0.02 were maintained in both centers with internal validation, while external validation deteriorated. Valuable predictors were mainly the trends of time-series variables such as laboratory results and vital signs. CONCLUSION: An ML approach that uses temporal and site-specific data achieved high performance in recognizing BC samples with a high probability for ICU-acquired BSI.
PURPOSE: We aimed to develop a machine-learning (ML) algorithm that can predict intensive care unit (ICU)-acquired bloodstream infections (BSI) among patients suspected of infection in the ICU. METHODS: The study was based on patients' electronic health records at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, USA, and at Rambam Health Care Campus (RHCC), Haifa, Israel. We included adults from whom blood cultures were collected for suspected BSI at least 48 h after admission. Clinical data, including time-series variables and their interactions, were analyzed by an ML algorithm at each site. Prediction ability for ICU-acquired BSI was assessed by the area under the receiver operating characteristics (AUROC) of ten-fold cross-validation and validation sets with 95% confidence intervals. RESULTS: The datasets comprised 2351 patients from BIDMC (151 with BSI) and 1021 from RHCC (162 with BSI). The median (inter-quartile range) age was 62 (51-75) and 56 (38-69) years, respectively; the median Acute Physiology and Chronic Health Evaluation II scores were 26 (21-32) and 24 (20-29), respectively. The means of the cross-validation AUROCs were 0.87 ± 0.02 for BIDMC and 0.93 ± 0.03 for RHCC. AUROCs of 0.89 ± 0.01 and 0.92 ± 0.02 were maintained in both centers with internal validation, while external validation deteriorated. Valuable predictors were mainly the trends of time-series variables such as laboratory results and vital signs. CONCLUSION: An ML approach that uses temporal and site-specific data achieved high performance in recognizing BC samples with a high probability for ICU-acquired BSI.
Entities:
Keywords:
Bacteremia; Early diagnosis; Intensive care unit; Machine learning; Nosocomial infection
Authors: Rodger D MacArthur; Mark Miller; Timothy Albertson; Edward Panacek; David Johnson; Leah Teoh; William Barchuk Journal: Clin Infect Dis Date: 2003-12-22 Impact factor: 9.079
Authors: F R Cockerill; J W Wilson; E A Vetter; K M Goodman; C A Torgerson; W S Harmsen; C D Schleck; D M Ilstrup; J A Washington; W R Wilson Journal: Clin Infect Dis Date: 2004-05-25 Impact factor: 9.079
Authors: Jens U Jensen; Lars Hein; Bettina Lundgren; Morten H Bestle; Thomas T Mohr; Mads H Andersen; Klaus J Thornberg; Jesper Løken; Morten Steensen; Zoe Fox; Hamid Tousi; Peter Søe-Jensen; Anne Ø Lauritsen; Ditte Strange; Pernille L Petersen; Nanna Reiter; Søren Hestad; Katrin Thormar; Paul Fjeldborg; Kim M Larsen; Niels E Drenck; Christian Ostergaard; Jesper Kjær; Jesper Grarup; Jens D Lundgren Journal: Crit Care Med Date: 2011-09 Impact factor: 7.598
Authors: Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuck Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger Journal: Crit Care Med Date: 2017-03 Impact factor: 7.598
Authors: Daniel Brooks; Andrew Smith; Douglas Young; Rachael Fulton; Malcolm G Booth Journal: Am J Infect Control Date: 2016-06-20 Impact factor: 2.918
Authors: Evelien de Jong; Jos A van Oers; Albertus Beishuizen; Piet Vos; Wytze J Vermeijden; Lenneke E Haas; Bert G Loef; Tom Dormans; Gertrude C van Melsen; Yvette C Kluiters; Hans Kemperman; Maarten J van den Elsen; Jeroen A Schouten; Jörn O Streefkerk; Hans G Krabbe; Hans Kieft; Georg H Kluge; Veerle C van Dam; Joost van Pelt; Laura Bormans; Martine Bokelman Otten; Auke C Reidinga; Henrik Endeman; Jos W Twisk; Ewoudt M W van de Garde; Anne Marie G A de Smet; Jozef Kesecioglu; Armand R Girbes; Maarten W Nijsten; Dylan W de Lange Journal: Lancet Infect Dis Date: 2016-03-02 Impact factor: 25.071
Authors: Anneroos W Boerman; Michiel Schinkel; Lotta Meijerink; Eva S van den Ende; Lara Ca Pladet; Martijn G Scholtemeijer; Joost Zeeuw; Anuschka Y van der Zaag; Tanca C Minderhoud; Paul W G Elbers; W Joost Wiersinga; Robert de Jonge; Mark Hh Kramer; Prabath W B Nanayakkara Journal: BMJ Open Date: 2022-01-04 Impact factor: 2.692
Authors: Christian Gosset; Jacques Foguenne; Mickaël Simul; Olivier Tomsin; Hayet Ammar; Nathalie Layios; Paul B Massion; Pierre Damas; André Gothot Journal: Sci Rep Date: 2021-10-13 Impact factor: 4.379
Authors: Sivasubramanium V Bhavani; Zachary Lonjers; Kyle A Carey; Majid Afshar; Emily R Gilbert; Nirav S Shah; Elbert S Huang; Matthew M Churpek Journal: Crit Care Med Date: 2020-11 Impact factor: 9.296